Anxiety and depression as risk factors of cardiovascular diseases: possibilities of medicamentous correction
- Authors: Makolkin VI1, Makolkin VI1
-
Affiliations:
- Issue: No 6 (2009)
- Pages: 44-48
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/276512
- ID: 276512
Cite item
Full Text
Abstract
The article is dedicated to the problem of psychopathological disorders in the internal medicine and their impact on the course of somatic, in particular cardiovascular diseases. General practitioners often are faced with depression and anxiety disorders. Given the fact that currently depression is considered as an independent factor of cardiovascular disease, and depression and anxiety more frequently occurs in patients with coronary heart disease than an average of population, timeliness of diagnosis and treatment of these disorders are critical issue for internists.
References
- Dobbels F, De Geast S, Vantees L, еt al. Depression and the heart: a systematic overview of difenition? Measurement, consequences and treatment of depression in cardiovascular disease. Eur J Cardiovasc Nurs 2000;1(1):45-55.
- Смулевич А.Б., Сыркин А.Л. Психокардиология. М., 2005. 778 с.
- Маколкин В.И., Ромасенко Л В. Психосоматические расстройства в клинике внутренних болезней. 2003. изд. Сервье С. 24.
- Carney RM, Rich MW, Velde, et al. Prevalence of maior depressive disorder in patients receiving beta-blockers therapy versus other medications. Amer J Med 1987;83(2):223-26.
- Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91(4):999-1005.
- Nemeroff CB, Musselman DL. Are platelet the link between depression and ischemic heart disease? Amer Heart J 2000;140(Suppl. 4):57-62.
- Погосова Г.В. Депрессия у больных ишемической болезнью сердца // Кардиология. 2002. № 5. С. 195-198.
- Смулевич А.Б. Депрессия при соматических и психических заболеваниях. М., 2003.
- Quattrocki FM, Baird A, Yurgelun-Todd D. Biligical aspects of the link beween smoking and depression. Harv Rev Psychiatry 2000;8(3):99-110.
- Zwieten PA, Mancia G. The metabolic syndrome - a therapeutic challenge. 2005. Van Zuiden Communications B.V. PO Box 2122, 2400 CC Alpena an den Rijn, the Netherlands.
- Романцова Т.И., Дедов И.И., Кузнецов И.С. Эндоканнабаноидная система: структура и потенциальные возможности в регуляции массы тела // Ожирение и метаболизм. 2006. № 4. С. 11.
- Troxler RG, Spraque EA, Albanese RA, et al. The association of elevated plasma Cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 1977. № 26. С. 151-162.
- Небиеридзе Д.В., Оганов Р.Г. Взаимосвязь тревожно-депрессивных расстройств с факторами риска атеросклероза. Бюллетень "КОМПАС, в мире депрессии". 2003.
- Maes M, Bosmans E, De Jongh R, et al. Increseased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9(11):853-58.
- Александровский Ю.А., Ромасенко Л.В. Психиатрическая помощь в общемедицинской практике. В кн.: Психиатрия национальное руководство. М., 2009. 992 с.
Supplementary files
